Correlation between the degree of cognitive impairment and emotional state in patients with Alzheimer’s disease.

Correlación entre disfunción cognitiva y estado emocional en pacientes con enfermedad de Alzheimer y su intervención.

• Zhichao Qiu Shanghai Urban Construction Vocation College, Shanghai, China. https://orcid.org/0009-0002-2505-8850
• Jingjing Cai Shanghai Urban Construction Vocation College, Shanghai, China. https://orcid.org/0009-0004-2057-8069
• Fanlin Xia Shanghai Urban Construction Vocation College, Shanghai, China. https://orcid.org/0009-0001-5288-9169

Keywords: Alzheimer’s disease, cognitive dysfunction, positive emotion, negative emotion

Abstract

This study aimed to investigate the correlation between cognitive dysfunction and emotional state in patients with Alzheimer’s disease and then propose intervention strategies. One hundred twenty-five patients with Alzheimer’s disease from June 2019 to May 2022 were selected as the study subjects and divided into two groups based on the degree of cognitive impairment, both receiving routine drug treatment and cognitive rehabilitation intervention. The Montreal Cognitive Assessment (MoCA) and the Positive and Negative Affect Scale (PANAS) were used to evaluate the cognitive function and emotional status of two groups of patients before the intervention and four and eight weeks of intervention and to analyze the correlations between the two. The results showed statistically significant differences between the two groups MoCA and PANAS scores (P<0.05). Before the intervention, the patient’s MoCA score was positively correlated with the PANAS positive emotion score and negatively correlated with the PANAS negative emotion score (P<0.05). After four and eight weeks of intervention, the patient’s MoCA score was positively correlated with the PANAS positive emotion score (P<0.05) and negatively correlated with the PANAS negative emotion score (P<0.05).

References

Lim S, Mohaimin S, Min D, Roberts T, Sohn Y.J, Wong J, Trinh-Shevrin C. Alzheimer’s disease and its related dementias among Asian Americans, Native Hawaiians, and Pacific Islanders: A scoping review. J Alzheimer’s Dis 2020; 77(2): 523-537.

Resnick B, Boltz M, Galik E, Fix S, Holmes S, Zhu S. Model testing of the factors that influence performance of Function Focused Care and function among assisted living residents. J Appl. Gerontol 2022; 41(2): 401-410.

Guo J, Ma Y, Liu Z, Wang F, Hou X, Chen J, Liu X. Performance of facial expression classification tasks in patients with obstructive sleep apnea. J Clin Sleep Med 2020; 16(4): 523-530.

Isik AT, Soysal P, Solmi M, Veronese N. Bi-directional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer’s disease: a narrative review. Int J Geriatr Psychiat 2019; 34(9): 1326-1334.

Guo M, Peng J, Huang X, Xiao L, Huang F, Zuo Z. Gut microbiome features of Chinese patients newly diagnosed with Alzheimer’s disease or mild cognitive impairment. J Alzheimer’s Dis 2021; 80(1): 299-310.

Chu CS, Li CT, Brunoni AR, Yang FC, Tseng PT, Tu YK, Liang CS. Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer’s disease and mild cognitive impairment: a component network meta-analysis. J Neurol Neurosur Ps 2021; 92(2): 195-203.

Sabbagh MN, Blennow K. Peripheral bio-markers for Alzheimer disease: update and progress. Neurol. Ther 2019; 8(2): 33-36.

Costanzo MC, Arcidiacono C, Rodolico A, Panebianco M, Signorelli MS. Diagnostic and interventional implications of tele-medicine in Alzheimer’s disease and mild cognitive impairment: a literature review. Int J Geriatr Psych 2020; 35(1): 12-28.

Cheng YW, Chiu MJ, Chen YF, Cheng TW, Lai YM, Chen TF. The contribution of vascular risk factors in neurodegenerative disorders: From mild cognitive impairment to Alzheimer’s disease. Alzheimer’s Res Ther 2020; 12(1): 1-10.

Li X, Qi G, Yu C, Lian G, Zheng H, Wu S, Yuan T, Zhou D. Cortical plasticity is correlated with cognitive improvement in Alzheimer’s disease patients after rTMS treatment. Brain Stimul 2021; 14(3): 503-510.

Boutoleau-Bretonnière C, Pouclet-Courtemanche H, Gillet A, Pouclet-Courtemanche H, Gillet A, Bernard A, Deruet AL, Gouraud I, El Haj M. The effects of confinement on neuropsychiatric symptoms in Alzheimer’s disease during the COVID-19 crisis. J Alzheimer’s Dis 2020; 76(1): 41-47.

Moon Y, Moon WJ, Kim JO, Kwon KJ, Han SH. Muscle strength is independently related to brain atrophy in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 2019; 47(4-6): 306-314.

Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Aisen PS. Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial. JAMA Neurol 2020; 77(9): 1099-1109.

Yoon SP, Grewal DS, Thompson AC, Polascik BW, Dunn C, Burke JR, Fekrat S. Retinal microvascular and neurodegenerative changes in Alzheimer’s disease and mild cognitive impairment compared with control participants. Ophthalmol Retina 2019; 3(6): 489-499.

Guo M, Peng J, Huang X, Xiao L, Huang F, Zuo Z. Gut microbiome features of Chinese patients newly diagnosed with Alzheimer’s disease or mild cognitive impairment. J Alzheimer Dis 2021; 80(1): 299-310.